Quotient Therapeutics

London, United Kingdom

Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.

$50.0M raised

Nov 2023

Seed

Biotechnology Life Science Medical

Top Investors

Flagship Pioneering

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Quotient Therapeutics

How much funding has Quotient Therapeutics raised?

Quotient Therapeutics has raised $50.0M in total funding. The most recent round was Seed. The last funding was announced in November 2023.

Who are Quotient Therapeutics's investors?

Quotient Therapeutics's investors include Flagship Pioneering.

Where is Quotient Therapeutics headquartered?

Quotient Therapeutics is headquartered in London, United Kingdom.

What does Quotient Therapeutics do?

Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.

What stage is Quotient Therapeutics at?

Quotient Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 21, 2023.

MLA

"Quotient Therapeutics — Funding & Investors." VCBacked, November 21, 2023, https://www.vcbacked.co/company/quotient-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2023). Quotient Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/quotient-therapeutics

Wikipedia (cite web)

{{cite web |title=Quotient Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quotient-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 21, 2023.